šŸ“£ Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Reduced ability to neutralize the Omicron variant among adults after infection and complete vaccination with BNT162b2, ChAdOx1, or CoronaVac and heterologous boosting. (2023)

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-023-34035-9

PubMed Identifier: 37156846

Publication URI: http://europepmc.org/abstract/MED/37156846

Type: Journal Article/Review

Volume: 13

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322